Home
>
National Drug Code (NDC)
>
Neomycin Polymyxin B Sulfates and Dexamethasone
Neomycin Polymyxin B Sulfates and Dexamethasone - 50436-0830-1 - (Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone)
Drug Information of Neomycin Polymyxin B Sulfates and Dexamethasone
| Product NDC: | 50436-0830 |
| Proprietary Name: | Neomycin Polymyxin B Sulfates and Dexamethasone |
| Non Proprietary Name: | Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone |
| Active Ingredient(s): | 1; 3.5; 10000 mg/mL; mg/mL; [USP'U]/mL & nbsp; Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SUSPENSION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Neomycin Polymyxin B Sulfates and Dexamethasone
| Product NDC: | 50436-0830 |
| Labeler Name: | Unit Dose Services |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA064135 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19950913 |
Package Information of Neomycin Polymyxin B Sulfates and Dexamethasone
| Package NDC: | 50436-0830-1 |
| Package Description: | 5 mL in 1 CARTON (50436-0830-1) |
NDC Information of Neomycin Polymyxin B Sulfates and Dexamethasone
| NDC Code | 50436-0830-1 |
| Proprietary Name | Neomycin Polymyxin B Sulfates and Dexamethasone |
| Package Description | 5 mL in 1 CARTON (50436-0830-1) |
| Product NDC | 50436-0830 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone |
| Dosage Form Name | SUSPENSION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19950913 |
| Marketing Category Name | ANDA |
| Labeler Name | Unit Dose Services |
| Substance Name | DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Strength Number | 1; 3.5; 10000 |
| Strength Unit | mg/mL; mg/mL; [USP'U]/mL |
| Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
